(Q37269057)

19 August 2017

Nucleostemin and ASPP2 expression is correlated with pituitary adenoma proliferation (English)

1 reference

19 August 2017

1 reference

Lin Ma

1

1 reference

19 August 2017

Zhi-Min Chen

2

1 reference

19 August 2017

Xue-Yuan Li

3

1 reference

19 August 2017

Xin-Jun Wang

4

1 reference

19 August 2017

Ji-Xin Shou

5

1 reference

19 August 2017

Xu-Dong Fu

6

1 reference

19 August 2017

4 September 2013

1 reference

19 August 2017

1 reference

19 August 2017

6

1 reference

19 August 2017

5

1 reference

19 August 2017

1313-1318

1 reference

ASPP1 and ASPP2 bind active RAS, potentiate RAS signalling and enhance p53 activity in cancer cells

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3813498

Nucleostemin maintains self-renewal of embryonic stem cells and promotes reprogramming of somatic cells to pluripotency

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3813498

Inhibitory member of the apoptosis-stimulating proteins of the p53 family (iASPP) interacts with protein phosphatase 1 via a noncanonical binding motif

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3813498

Atypical pituitary adenomas: incidence, clinical characteristics, and implications

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3813498

Mdm2 and mdmX prevent ASPP1 and ASPP2 from stimulating p53 without targeting p53 for degradation

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3813498

A multistep, GTP-driven mechanism controlling the dynamic cycling of nucleostemin

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3813498

The effect of knocking-down nucleostemin gene expression on the in vitro proliferation and in vivo tumorigenesis of HeLa cells

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3813498

iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3813498

A nucleolar mechanism controlling cell proliferation in stem cells and cancer cells

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3813498

ASPP proteins specifically stimulate the apoptotic function of p53

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3813498

Control of ASPP2/(53BP2L) protein levels by proteasomal degradation modulates p53 apoptotic function

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3813498

Multiregional sampling reveals a homogenous distribution of Ki-67 proliferation rate in pituitary adenomas

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3813498

Expression of cell proliferation markers in pituitary adenomas--correlation and clinical relevance of MIB-1 and anti-topoisomerase-IIalpha.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3813498

Transsphenoidal microsurgery for Cushing disease. A report of 216 cases

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3813498

Differential expression of folate receptor alpha in pituitary adenomas and its relationship to tumor behavior.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3813498

A clinicopathological and immunohistochemical study of clinically non-functioning pituitary adenomas: a single institutional experience.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3813498

Apoptosis stimulating protein of p53 (ASPP2) expression differs in diffuse large B-cell and follicular center lymphoma: correlation with clinical outcome

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3813498

Tumors of the central nervous system in Taiwan, Republic of China

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3813498

Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas

3 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24179515

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The evolution of epigenetics

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24179515

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Expression of Ki-67 antigen in nonfunctioning pituitary adenomas: correlation with growth velocity and invasiveness

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24179515

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3892/OL.2013.1562

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

24179515

1 reference